Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma

NCT01924819 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

574

Enrollment

NETWORK

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
RADIATION: Preoperative chemoradiotherapy
PROCEDURE: Gastric resection

Sponsor

Australasian Gastro-Intestinal Trials Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]